...
首页> 外文期刊>Medicine. >The association between maternal hyperglycemia and perinatal outcomes in gestational diabetes mellitus patients: A retrospective cohort study
【24h】

The association between maternal hyperglycemia and perinatal outcomes in gestational diabetes mellitus patients: A retrospective cohort study

机译:妊娠糖尿病患者母亲高血糖与围产期结局的关联:一项回顾性队列研究

获取原文
获取原文并翻译 | 示例

摘要

Pregnancies complicated by gestational diabetes mellitus (GDM) are associated with increased risks of adverse maternal and fetal outcomes. The risks of adverse pregnancy outcomes differ depending on the glucose values among GDM patients. For accurate and effective prenatal counseling, it is necessary to understand the relationship between different maternal hyperglycemia values and the severity of adverse outcomes. With this objective, this study reexamines the relationship between maternal hyperglycemia versus maternal and perinatal outcomes in GDM patients. For this study, maternal hyperglycemia was diagnosed using the 2-step diagnostic approach.Medical records of 3434 pregnant women, who received the 50-g glucose challenge test (GCT) between March 2001 and April 2013, were reviewed. As a result, 307 patients were diagnosed with GDM, and they were divided into 2 groups according to their fasting glucose levels. A total of 171 patients had normal fasting glucose level (<95mg/dL), and 136 patients had abnormal fasting glucose level (95mg/dL). The 50-g GCT results were subdivided by 20-unit increments (140-159, n = 123; 160-179, n = 84; 180-199, n = 50; and 200, n = 50), and the maternal and perinatal outcomes were compared against the normal 50-g GCT group (n = 307).Maternal fasting blood glucose (FBG) level showed clear association with adverse perinatal outcomes. The odds ratio (OR) of macrosomia was 6.72 (95% CI: 2.59-17.49, P<0.001) between the 2 groups. The ORs of large for gestational age (LGA) and neonatal hypoglycemia were 3.75 (95% CI: 1.97-7.12, P<0.001) and 1.65 (95% CI: 0.79-3.43, P = 0.183), respectively. Also, the results of the 50-g GCT for each category showed strong association with increased risks of adverse perinatal outcomes compared to the normal 50-g GCT group. The OR of macrosomia (up to 20.31-fold), LGA (up to 6.15-fold), and neonatal hypoglycemia (up to 84.00-fold) increased with increasing 50-g GCT result.
机译:妊娠并发妊娠糖尿病(GDM)会增加孕妇和胎儿不利结局的风险。妊娠不良后果的风险因GDM患者中的葡萄糖值而异。为了进行准确有效的产前咨询,有必要了解不同的孕妇高血糖值与不良后果严重程度之间的关系。出于这个目的,本研究重新检查了GDM患者的孕妇高血糖与孕妇和围产期结局之间的关系。在这项研究中,母体高血糖症通过两步诊断方法进行诊断。回顾了2001年3月至2013年4月间接受50 g葡萄糖激发试验(GCT)的3434名孕妇的医学记录。结果,有307名被诊断为GDM的患者,根据其空腹血糖水平分为2组。共有171例空腹血糖水平正常(<95mg / dL),有136例空腹血糖水平异常(95mg / dL)。将50 g GCT结果细分为20个单位的增量(140-159,n = 123; 160-179,n = 84; 180-199,n = 50; 200,n = 50),以及母体和将围产期结局与正常的50 g GCT组进行比较(n = 307)。母亲的空腹血糖(FBG)水平与围产期不良结局明显相关。两组之间的巨大儿比值比(OR)为6.72(95%CI:2.59-17.49,P <0.001)。胎龄(LGA)和新生儿低血糖的OR分别为3.75(95%CI:1.97-7.12,P <0.001)和1.65(95%CI:0.79-3.43,P = 0.183)。此外,与正常的50 g GCT组相比,每个类别的50 g GCT结果显示出与围产期不良结局风险增加的强烈关联。随着50-g GCT结果的增加,巨大儿(最高20.31倍),LGA(最高6.15倍)和新生儿低血糖(最高84.00倍)的OR升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号